| An agent-based diffusion model with consumer and brand agents ME Schramm, KJ Trainor, M Shanker, MY Hu Decision Support Systems 50 (1), 234-242, 2010 | 100 | 2010 |
| Stock market response to strategic technical alliances between drug and biotechnology firms D Liu, X Pu, ME Schramm Journal of Product Innovation Management 33 (5), 549-569, 2016 | 20 | 2016 |
| Perspective: The evolution of R&D conduct in the pharmaceutical industry ME Schramm, MY Hu Journal of Product Innovation Management 30, 203-213, 2013 | 17 | 2013 |
| Consumer choices among service brands offering ethical attributes E Bridges, M Schramm, A Roy The Service Industries Journal 39 (15-16), 1167-1189, 2019 | 11 | 2019 |
| The moderating role of mindfulness in new product evaluation ME Schramm, MY Hu Atlantic Marketing Journal 3 (3), 1, 2014 | 9 | 2014 |
| Electric appliance advertising: the role of the Good Housekeeping Institute EL Paulson, ME Schramm Journal of Historical Research in Marketing 9 (1), 41-65, 2017 | 6 | 2017 |
| The false claims act: a review and policy recommendations M E. Schramm, J L. Herbst, A Mattie International Journal of Pharmaceutical and Healthcare Marketing 8 (3), 295-313, 2014 | 5 | 2014 |
| Orphan Drugs and Big Pharma Strategy: The Curious Case of Humira. DO Hartman, ME Schramm Journal of Case Studies 37 (2), 61-80, 2019 | 3 | 2019 |
| Framing the strategic R&D paradigm shift in Big Pharma: a content analysis of pharmaceutical annual reports ME Schramm, KR Place, AV Laskin Journal of Communication Management, 2022 | 2 | 2022 |
| The relationship between competitive pricing and direct-to-consumer advertising: How to manage DTC advertising of Rx drugs in an integrated marketing mix strategy A Roy, ME Schramm Journal of Advertising Research 60 (3), 305-323, 2020 | 2 | 2020 |
| Patient participation: the impact of diagnosis and individual characteristics ME Schramm, TG Chowdhury, M Odenwaelder, EA Lisk The Service Industries Journal 43 (13-14), 989-1009, 2023 | 1 | 2023 |
| First Amendment Protection of Evidence-Based Promotion of Prescription Drugs: A Study of Published Clinical Evidence Supporting Off-Label Promotion in the USA JL Herbst, VE Richards, ME Schramm, A Mattie Pharmaceutical Medicine 31, 309-315, 2017 | 1 | 2017 |
| Value Relevance of Innovation in the Pharmaceutical Industry ME Schramm Kent State University, 2011 | 1 | 2011 |
| Stock Return Response to Strategic Technical Alliances in the Pharmaceutical Industry D Liu, X Pu, ME Schramm Proceedings of the Northeast Business & Economics Association, 191-193, 2012 | | 2012 |
| Valuation of Product Portfolio Strategy in the Pharmaceutical Industry ME Schramm, MY Hu Proceedings of the Northeast Business & Economics Association, 434-435, 2011 | | 2011 |
